Skip to main content

MindWalk Holdings Corp.

corporate_fare Company Profile

MindWalk Holdings Corp.

HYFT·NASDAQ·Life Sciences·CIK 0001715925

MindWalk Holdings Corp. is a Bio-Native AI company that uses artificial intelligence, proprietary biological pattern analysis, and wet-lab capabilities to aid in the discovery of new therapies. The company develops BioIntelligence infrastructure, which is essential for life sciences AI and increasingly agentic AI. This infrastructure is designed to integrate AI, data, and full-stack wet lab capabilities into a single connected discovery ecosystem. At the center of its operations is HYFT Technology, the company's patented, function-aware representation of biology. This technology has been refined over 20 years of curation, resulting in a biological representation of 660 million patterns and 25 billion relationships across sequence and structural biology. MindWalk Holdings Corp. positions ReefIQ, which is powered by HYFT Technology, as a biological context layer for life sciences. ReefIQ enriches biological data as it is ingested and links it to biological meaning. This allows the LensAI reasoning and application layer, along with any customer-selected AI models or agents, to reason over a governed, evidence-linked representation rather than isolated files. The company's executive headquarters are located at Industrious 823 Congress Ave, Suite 300, Austin, Texas 78701. Its registered and records office is at 1600 - 925 West Georgia Street, Vancouver, British Columbia V6C 3L2, Canada. MindWalk Holdings Corp. trades on the Nasdaq Capital Market under the ticker symbol "HYFT", effective September 4, 2025.

MindWalk Holdings Corp. (NASDAQ:HYFT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for HYFT at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • MindWalk Announces Breakthrough Discovery Targeting Pathogenic TDP-43, Validating Platform Precision
  • MindWalk Announces Breakthrough in Universal Influenza Program with Novel Functional Insight

Financial Snapshot

Fiscal year ended April 30, 2026
Revenue
CA$15.56M CAD
Net Income
-CA$13.95M CAD
Op. Cash Flow
-CA$12.46M CAD
Free Cash Flow
-CA$12.86M CAD
Gross Profit
CA$9.15M CAD
Cash & Equivalents
CA$11.35M CAD
Debt / Equity
0.00×
Net Margin
-89.7%
Source: 20-F · filed 2026-07-22 · accession 0001193125-26-312694

Insider Transactions

HYFT files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$1.37 +0.06% today
52-week range · as of 2026-09-14 $0.99 – $2.99
Market cap
$64.54M
Volume
241.4K (1.5× avg)
3-mo avg 156.1K
Live data · 2026-09-18 19:06 UTC · Market open

show_chartPrice Chart

Loading chart...

feed HYFT - Filings & News (Page 2)

HYFT
Jan 14, 2026, 10:04 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.30
Real-time Price: $1.37 info
Change: -$0.930 (-40%) info
Market Cap: $64.543M info
HYFT
Jan 09, 2026, 8:01 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.04
Real-time Price: $1.37 info
Change: -$1.67 (-55%) info
Market Cap: $64.543M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets